These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6106711)

  • 1. Pharmacology of 1-(3,4-dichlorobenzyl)-3,4,5,6-tetrahydro-2(1H)-pyrimidone, a novel antidepressant compound with antianxiety activity.
    Ellis KO; Wessels FL; Burns RH; Pong SF
    J Pharm Sci; 1980 Oct; 69(10):1198-1202. PubMed ID: 6106711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, synthesis, and pharmacology of metabolites of 1-(3,4-dichlorobenzyl)-3,4,5,6-tetrahydro-2(1H)-pyrimidone.
    Schwan TJ; Ellis KO; Wessels FL; Pugh D; Bell R
    J Pharm Sci; 1980 Oct; 69(10):1203-5. PubMed ID: 6106712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(substituted benzyl)-3,4,5,6-tetrahydro-2(1H)-pyrimidones: a series with stimulant and depressant activities.
    Ellis KO; Schwan TJ; Wessels FL; Miles NJ
    J Pharm Sci; 1980 Oct; 69(10):1194-8. PubMed ID: 6106710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties.
    Christensen AV; Fjalland B; Pedersen V; Danneskiold-Samsoe P; Svendsen O
    Eur J Pharmacol; 1977 Jan; 41(2):153-62. PubMed ID: 12988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-phenyl-2-furamidines: a new chemical class of potential antidepressants.
    Pong SF; Pelosi SS; Wessels FL; Yu CN; Burns RH; White RE; Anthony DR; Ellis KO; Wright GC; White RL
    Arzneimittelforschung; 1983; 33(10):1411-6. PubMed ID: 6140016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antidepressant activity of 5-(4-dimethylaminobenzyl)imidazolidine-2,4-dione.
    Wessels FL; Schwan TJ; Pong SF
    J Pharm Sci; 1980 Sep; 69(9):1102-4. PubMed ID: 6106054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine.
    George T; Kaul CL; Grewal RS; Tahilramani R
    J Med Chem; 1971 Oct; 14(10):913-5. PubMed ID: 4398920
    [No Abstract]   [Full Text] [Related]  

  • 9. Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
    Soroko FE; Mehta NB; Maxwell RA; Ferris RM; Schroeder DH
    J Pharm Pharmacol; 1977 Dec; 29(12):767-70. PubMed ID: 22628
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
    Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
    Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant properties of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline hydrochloride (AD-1308) and its mechanism of action as compared with tricyclic antidepressants.
    Karasawa T; Furukawa K; Ochi Y; Ito T; Yoshida K; Shimizu M
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):283-302. PubMed ID: 6773486
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
    Boksay IJ; Popendiker K; Weber RO; Söder A
    Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic basis for therapeutic interest in bupropion.
    Soroko FE; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride.
    Nakagawa T; Ukai K; Kubo S
    Arzneimittelforschung; 1993 Jan; 43(1):11-5. PubMed ID: 8447840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.
    Hyttel J
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):277-95. PubMed ID: 6128769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.